F.Biotechnology Dis.Fd.A-H1 EUR H/  LU1803069274  /

Fonds
NAV2/27/2024 Chg.+0.1900 Type of yield Investment Focus Investment company
13.0500EUR +1.48% reinvestment Equity Worldwide Franklin Templeton 
 

Investment goal

The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Biotechnology
Benchmark: NASDAQ Biotechnology Index
Business year start: 7/1
Last Distribution: -
Depository bank: J.P. Morgan SE, Luxembourg Branch
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland
Fund manager: Evan McCulloch, Wendy Lam, Akiva Felt
Fund volume: 1.76 bill.  USD
Launch date: 4/6/2018
Investment focus: -

Conditions

Issue surcharge: 5.75%
Max. Administration Fee: 1.50%
Minimum investment: 1,000.00 EUR
Deposit fees: 0.14%
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Franklin Templeton
Address: Schottenring 16, 2.OG, 1010, Wien
Country: Austria
Internet: www.franklintempleton.at
 

Assets

Stocks
 
95.33%
Cash
 
0.12%
Others
 
4.55%

Countries

United States of America
 
79.69%
Denmark
 
3.86%
Netherlands
 
3.75%
United Kingdom
 
3.36%
Ireland
 
2.76%
Canada
 
0.64%
Cayman Islands
 
0.63%
Germany
 
0.41%
Bermuda
 
0.23%
Cash
 
0.12%
Others
 
4.55%

Branches

Pharma/Biotechnology
 
89.56%
Healthcare services
 
5.36%
Healthcare appliances
 
0.41%
Cash
 
0.12%
Others
 
4.55%